XML 52 R43.htm IDEA: XBRL DOCUMENT
v3.22.2

License and Collaboration Agreements (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | ---
Sep. 30, 2020 | Jun. 30, 2022 | Jun. 30, 2021 | Mar. 31, 2020 | Jun. 30, 2022 | Jun. 30, 2021
Research and License Agreements |  |  |  |  |  |
Revenue from collaboration and license agreements |  | $ 75,000 | $ 142 |  | $ 75,000 | $ 1,055,582
Apollomics, Inc. |  |  |  |  |  |
Research and License Agreements |  |  |  |  |  |
Revenue from collaboration and license agreements |  |  |  |  |  | $ 1,100,000
Up-front payment received |  |  |  | $ 9,000,000.0 |  |
Milestones based on achievement of certain clinical and regulatory events |  |  |  | 75,000,000.0 |  |
Milestone payment upon achievement of specified net sales thresholds for all licensed products |  |  |  | $ 105,000,000.0 |  |
Milestone revenue recognized based on achievement of certain clinical and regulatory events | $ 1,000,000.0 |  |  |  |  |
Apollomics, Inc. | Maximum |  |  |  |  |  |
Research and License Agreements |  |  |  |  |  |
Tiered percentage of annual net sales |  |  |  | 15.00% |  |

X
- Definition The amount of revenue to be received upon the achievement of specified net sales thresholds for all licensed products. + References No definition available. + Details
Name: | glyc_AchievementOfSpecifiedNetSalesThresholdsForAllLicensedProducts
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | glyc_ArrangementsAndNonarrangementTransactionsLineItems
Namespace Prefix: | glyc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of development and regulatory specific approval milestones based on achievement of certain clinical and regulatory events. + References No definition available. + Details
Name: | glyc_DevelopmentAndRegulatoryApprovalMilestonesClinicalAndRegulatoryEvents
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The milestone revenue recognized. + References No definition available. + Details
Name: | glyc_MilestoneRevenueRecognized
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The entitled royalty payments to be received based on a tiered percentage of annual net sales. + References No definition available. + Details
Name: | glyc_TieredPercentageOfAnnualNetSales
Namespace Prefix: | glyc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of up-front payment received under terms of the agreement. + References No definition available. + Details
Name: | glyc_UpFrontPaymentReceived
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=glyc_ApollomicMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |